Fig. 3From: The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancerRepresentative immunohistochemical (IHC) staining of CD3, CD4, CD68 and CD163 in prostate cancer tissues. A Representative images showing CD3 expression. B Representative images showing CD4 expression. C Representative images showing CD8 expression. D Representative images showing CD68 expression. E Representative images showing CD163 expression. Original magnification, × 200Back to article page